PubMed:32881209
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 29-37 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 49-59 | Disease | denotes | Thrombosis | http://purl.obolibrary.org/obo/MONDO_0000831 |
T3 | 82-106 | Disease | denotes | Coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 108-116 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 179-187 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 285-293 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 305-317 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
T8 | 394-410 | Disease | denotes | thrombocytopenia | http://purl.obolibrary.org/obo/MONDO_0002049 |
T9 | 540-548 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T10 | 848-856 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T11 | 868-880 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
T12 | 909-933 | Disease | denotes | Coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 935-943 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 956-968 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
T15 | 1268-1276 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 61-62 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T2 | 121-122 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 274-275 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 443-454 | http://purl.obolibrary.org/obo/PR_000007299 | denotes | prothrombin |
T5 | 725-726 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 775-776 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 1304-1308 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1292-1303 | http://purl.obolibrary.org/obo/GO_0050817 | denotes | coagulation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 16-23 | Species | denotes | Patient | Tax:9606 |
4 | 29-37 | Disease | denotes | COVID-19 | MESH:C000657245 |
5 | 49-59 | Disease | denotes | Thrombosis | MESH:D013927 |
28 | 82-106 | Disease | denotes | Coronavirus disease 2019 | MESH:C000657245 |
29 | 108-116 | Disease | denotes | COVID-19 | MESH:C000657245 |
30 | 161-178 | Species | denotes | novel coronavirus | Tax:2697049 |
31 | 179-189 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
32 | 231-250 | Disease | denotes | respiratory illness | MESH:D012140 |
33 | 285-293 | Disease | denotes | COVID-19 | MESH:C000657245 |
34 | 305-317 | Disease | denotes | coagulopathy | MESH:D001778 |
35 | 368-387 | Disease | denotes | hyperfibrinogenemia | |
36 | 394-410 | Disease | denotes | thrombocytopenia | MESH:D013921 |
37 | 507-522 | Disease | denotes | thromboembolism | MESH:D013923 |
38 | 526-534 | Species | denotes | patients | Tax:9606 |
39 | 540-548 | Disease | denotes | COVID-19 | MESH:C000657245 |
40 | 589-596 | Species | denotes | patient | Tax:9606 |
41 | 848-856 | Disease | denotes | COVID-19 | MESH:C000657245 |
42 | 868-880 | Disease | denotes | coagulopathy | MESH:D001778 |
43 | 909-933 | Disease | denotes | Coronavirus disease 2019 | MESH:C000657245 |
44 | 935-943 | Disease | denotes | COVID-19 | MESH:C000657245 |
45 | 956-968 | Disease | denotes | coagulopathy | MESH:D001778 |
46 | 1014-1033 | Disease | denotes | hyperfibrinogenemia | |
47 | 1058-1073 | Disease | denotes | thromboembolism | MESH:D013923 |
48 | 1231-1239 | Species | denotes | patients | Tax:9606 |
49 | 1268-1276 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 231-250 | Phenotype | denotes | respiratory illness | http://purl.obolibrary.org/obo/HP_0002086 |
T2 | 305-317 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
T3 | 343-359 | Phenotype | denotes | elevated D-dimer | http://purl.obolibrary.org/obo/HP_0033106 |
T4 | 368-387 | Phenotype | denotes | hyperfibrinogenemia | http://purl.obolibrary.org/obo/HP_0011899 |
T5 | 394-410 | Phenotype | denotes | thrombocytopenia | http://purl.obolibrary.org/obo/HP_0001873 |
T6 | 423-459 | Phenotype | denotes | prolongation of the prothrombin time | http://purl.obolibrary.org/obo/HP_0008151 |
T7 | 507-522 | Phenotype | denotes | thromboembolism | http://purl.obolibrary.org/obo/HP_0001907 |
T8 | 868-880 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
T9 | 956-968 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
T10 | 989-1005 | Phenotype | denotes | elevated D-dimer | http://purl.obolibrary.org/obo/HP_0033106 |
T11 | 1014-1033 | Phenotype | denotes | hyperfibrinogenemia | http://purl.obolibrary.org/obo/HP_0011899 |
T12 | 1058-1073 | Phenotype | denotes | thromboembolism | http://purl.obolibrary.org/obo/HP_0001907 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-60 | Sentence | denotes | Approach to the Patient with COVID-19-Associated Thrombosis: |
T2 | 61-81 | Sentence | denotes | A Case-Based Review. |
T3 | 82-190 | Sentence | denotes | Coronavirus disease 2019 (COVID-19) is a current global pandemic caused by the novel coronavirus SARS-CoV-2. |
T4 | 191-460 | Sentence | denotes | Alongside its potential to cause severe respiratory illness, studies have reported a distinct COVID-19-associated coagulopathy that is characterized by elevated D-dimer levels, hyperfibrinogenemia, mild thrombocytopenia, and slight prolongation of the prothrombin time. |
T5 | 461-707 | Sentence | denotes | Studies have also reported increased rates of thromboembolism in patients with COVID-19, but variations in study methodologies, patient populations, and anticoagulation strategies make it challenging to distill implications for clinical practice. |
T6 | 708-881 | Sentence | denotes | Here, we present a practical review of current literature and uses a case-based format to discuss the diagnostic approach and management of COVID-19-associated coagulopathy. |
T7 | 882-908 | Sentence | denotes | IMPLICATIONS FOR PRACTICE: |
T8 | 909-1074 | Sentence | denotes | Coronavirus disease 2019 (COVID-19)-associated coagulopathy is characterized by elevated D-dimer levels, hyperfibrinogenemia, and increased rates of thromboembolism. |
T9 | 1075-1199 | Sentence | denotes | Current management guidelines are based on limited evidence from retrospective studies that should be interpreted carefully. |
T10 | 1200-1489 | Sentence | denotes | At this time, all hospitalized patients with suspected or confirmed COVID-19 should receive coagulation test surveillance and standard doses of prophylactic anticoagulation until prospective randomized controlled trials yield definitive information in support of higher prophylactic doses. |